Idiopathic pulmonary fibrosis (IPF) is characterized by progressive pulmonary scarring,
decline in lung function, and often results in death within 3–5 five years after diagnosis …

Idiopathic pulmonary fibrosis (IPF) is characterized by progressive fibroblast and
myofibroblast proliferation, and extensive deposition of extracellular matrix (ECM). Fibroblast …

The pathogenesis of pulmonary fibrosis involves lung epithelial injury and aberrant
proliferation of fibroblasts, and results in progressive pulmonary scarring and declining lung …

Fibroblast growth factor (FGF) signaling has been implicated in the pathogenesis of
pulmonary fibrosis. Mice lacking FGF2 have increased mortality and impaired epithelial …

Idiopathic pulmonary fibrosis (IPF) is characterized by an accumulation of extracellular
matrix proteins and fibroblasts in the distal airways. Key developmental lung signaling …

Background Recent clinical studies show that tyrosine kinase inhibitors slow the rate of lung
function decline and decrease the number of acute exacerbations in patients with Idiopathic …

Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal lung disease characterized by
the expansion of the fibroblast/myofibroblast population and aberrant remodeling. However …

Pulmonary fibrosis complicates a number of disease processes and leads to substantial
morbidity and mortality. Idiopathic pulmonary fibrosis (IPF) is perhaps the most pernicious …

Idiopathic pulmonary fibrosis (IPF) is an important public health problem, and it has few
treatment options given its poorly understood etiology; however, epithelial to mesenchymal …

Idiopathic pulmonary fibrosis (IPF) is a progressive disease characterized by fibroblast
proliferation and excess deposition of collagen and other extracellular matrix (ECM) …